Search

Membrane trafficking pathways mediate key microglial activities such as cell migration, cytokine secretion, and phagocytosis. However, the underlying molecular mechanism remains poorly understood. Previously, we found that synaptotagmin‐11 (Syt11), a non‐Ca2+‐binding Syt associated with Parkinson's disease (PD) and schizophrenia, inhibits cytokine release and phagocytosis in primary microglia. Here we reported the in vivo function of Syt11 in microglial immune responses using an inducible microglia‐specific Syt11‐conditional‐knockout (cKO) mouse strain. Syt11‐cKO resulted in activation of microglia and elevated mRNA levels of IL‐6, TNF‐α, IL‐1β, and iNOS in various brain regions under both resting state and LPS‐induced acute inflammation state in adult mice. In a PD mouse model generated by microinjection of preformed α‐synuclein fibrils into the striatum, a reduced number of microglia migrated toward the injection sites and an enhanced phagocytosis of α‐synuclein fibrils by microglia were found in Syt11‐cKO mice. To understand the molecular mechanism of Syt11 function, we identified its direct binding proteins vps10p‐tail‐interactor‐1a (vti1a) and vti1b. The linker domain of Syt11 interacted with both proteins and a peptide derived from it competitively inhibited the interaction of Syt11 with vti1a/vti1b in vitro and in cells. Importantly, application of this peptide induced more cytokine secretion in wild‐type microglia upon LPS treatment, phenocopying defects in Syt11 knockdown cells. Altogether, we propose that Syt11 inhibits microglial activation in vivo and regulates cytokine secretion through interactions with vti1a and vti1b. [ABSTRACT FROM AUTHOR]

α‐Synuclein is a central player in Parkinson's disease (PD) pathology. Various point mutations in α‐synuclein have been identified to alter the protein‐phospholipid binding behavior and cause PD. Therefore, exploration of α‐synuclein‐phospholipid interaction is important for understanding the PD pathogenesis and helping the early diagnosis of PD. Herein, a phospholipid‐decorated liquid crystal (LC)‐aqueous interface is constructed to investigate the binding between α‐synucleins (wild‐type and six familial mutant A30P, E46K, H50Q, G51D, A53E and A53T) and phospholipid. The application of deep learning analyzes and reveals distinct LC signatures generated by the binding of α‐synuclein and phospholipid. This system allows for the identification of single point mutant α‐synucleins with an average accuracy of 98.3±1.3% in a fast and efficient manner. We propose that this analytical methodology provides a new platform to understand α‐synuclein‐lipid interactions, and can be potentially developed for easy identification of α‐synuclein mutations in common clinic. [ABSTRACT FROM AUTHOR]

Recent work has revealed that spontaneous release plays critical roles in the central nervous system, but how it is regulated remains elusive. Here, we report that synaptotagmin‐11 (Syt11), a Ca2+‐independent Syt isoform associated with schizophrenia and Parkinson's disease, suppressed spontaneous release. Syt11‐knockout hippocampal neurons showed an increased frequency of miniature excitatory post‐synaptic currents while over‐expression of Syt11 inversely decreased the frequency. Neither knockout nor over‐expression of Syt11 affected the average amplitude, suggesting the pre‐synaptic regulation of spontaneous neurotransmission by Syt11. Glutathione S‐transferase pull‐down, co‐immunoprecipitation, and affinity‐purification experiments demonstrated a direct interaction of Syt11 with vps10p‐tail‐interactor‐1a (vti1a), a non‐canonical SNARE protein that maintains spontaneous release. Importantly, knockdown of vti1a reversed the phenotype of Syt11 knockout, identifying vti1a as the main target of Syt11 inhibition. Domain analysis revealed that the C2A domain of Syt11 bound vti1a with high affinity. Consistently, expression of the C2A domain alone rescued the phenotype of elevated spontaneous release in Syt11‐knockout neurons similar to the full‐length protein. Altogether, our results suggest that Syt11 inhibits vti1a‐containing vesicles during spontaneous release. [ABSTRACT FROM AUTHOR]

A liquid crystal biosensor based on DNA aptamer for sensitive detection of Parkinson's Disease (PD) related alpha-synuclein was developed. This LC biosensor is constructed using a simple and label free method, and it not only enables early PD diagnosis, but also provides a general platform for detection based on DNA aptamer. [ABSTRACT FROM AUTHOR]

Abstract: The ambient resting dopamine (DA) concentration in brain regulates cognition and motivation. Despite its importance, resting DA level in vivo remains elusive. Here, by high-frequency stimulation of the medial forebrain bundle and immediately following the stimulus-induced DA overflow, we recorded a DA “undershoot” which is a temporal reduction of DA concentration to a level below the baseline. Based on the DA undershoot, we predicted a resting DA concentration of ∼73nM in rat striatum in vivo. Simulation studies suggested that removing basal DA by DAT during the post-stimulation inhibition of tonic DA release caused the DA undershoot, and the resting concentration of DA modulated the kinetics of the evoked DA transient. The DA undershoot was eliminated by either blocking D2 receptors with haloperidol or blocking the DA transporter (DAT) with cocaine. Therefore, the impulse-dependent resting DA concentration is in the tens of nanomolar range and is modulated by the presynaptic D2 receptors and the DAT in vivo. [Copyright &y& Elsevier]

Non-technical summary Ca2+-regulated axon terminal exocytosis is essential for neuronal communication in the CNS. Besides, the somata may also undergo Ca2+-dependent exocytosis in some neurons in the brain. In the present work we recorded activity/Ca2+-dependent secretion in somata of the mesencephalic trigeminal nucleus (MeV). Following nerve activity, somatic secretion signals are recorded as changes in membrane surface area, as measured by the membrane capacitance. The depolarization-induced somatic exocytosis correlates with transient reduction in the GABA-mediated postsynaptic currents. These results implicated that the somatic secretion may play a role in bidirectional communication between pre- and post-connected neurons in the sensory MeV brain slice neurons. [ABSTRACT FROM AUTHOR]

J. Neurochem. (2011) 119, 342-353. Abstract Action potential (AP) patterns and dopamine (DA) release are known to correlate with rewarding behaviors, but how codes of AP bursts translate into DA release in vivo remains elusive. Here, a given AP pattern was defined by four codes, termed total AP number, frequency, number of AP bursts, and interburst time [ N, f, b, i].. The 'burst effect' was calculated by the ratio (γ) of DA overflow by multiple bursts to that of a single burst when total AP number was fixed. By stimulating the medial forebrain bundle using AP codes at either physiological (20 Hz) or supraphysiological (80 Hz) frequencies, we found that DA was released from two kinetically distinct vesicle pools, the fast-releasable pool (FRP) and prolonged-releasable pool (PRP), in striatal dopaminergic terminals in vivo. We examined the effects of vesicle pools on AP-pattern dependent DA overflow and found, with given 'burst codes' [ b = 8, i = 0.5 s], a large total AP number [ N = 768, f = 80 Hz] produced a facilitating burst-effect (γ[ b8/ b1] = 126 ± 3%), while a small total AP number [ N = 96, 80 Hz] triggered a depressing-burst-effect (γ[ b8/ b1] = 29 ± 4%). Furthermore, we found that the PRP (but not the FRP) predominantly contributed to the facilitating-burst-effect and the FRP played an important role in the depressing-burst effect. Thus, our results suggest that striatal DA release captures pre-synaptic AP pattern information through different releasable pools. [ABSTRACT FROM AUTHOR]

The article discusses the findings of a study to determine the separability of two types of exocytosis. It notes the function of Ca2+-regulated exocytosis the somata of dorsal root ganglions (DRG) in neurotransmitter and hormone release. The experiment cites the use of electrical stimulation to confirm the presence of distinct exocytosis and vesicle pools within DRG neurons without any effect on Ca2+ -independent but voltage-dependent secretion (CVIDS) exocytosis.

Schizophrenia is one of the most debilitating neuropsychiatric disorders, affecting 0.5-1.0% of the population worldwide. Its pathology, attributed to defects in synaptic transmission, remains elusive. The dystrobrevin-binding protein 1 (DTNBP1) gene, which encodes a coiled-coil protein, dysbindin, is a major susceptibility gene for schizophrenia. Our previous results have demonstrated that the sandy (sdy) mouse harbors a spontaneously occurring deletion in the DTNBP1 gene and expresses no dysbindin protein (Li, W., Q. Zhang, N. Oiso, E.K. Novak, R. Gautam, E.P. O'Brien, C.L. Tinsley, D.J. Blake, R.A. Spritz, N.G. Copeland, et al. 2003. Nat. Genet. 35:84-89). Here, using amperometry, whole-cell patch clamping, and electron microscopy techniques, we discovered specific defects in neurosecretion and vesicular morphology in neuroendocrine cells and hippocampal synapses at the single vesicle level in sdy mice. These defects include larger vesicle size, slower quantal vesicle release, lower release probability, and smaller total population of the readily releasable vesicle pool. These findings suggest that dysbindin functions to regulate exocytosis and vesicle biogenesis in endocrine cells and neurons. Our work also suggests a possible mechanism in the pathogenesis of schizophrenia at the synaptic level. [ABSTRACT FROM AUTHOR]

Abstract: Orexins have been shown to be implicated in the regulation of adrenal medulla functions. However, there are still inconsistent investigations on the effects of orexins on catecholamine release from chromaffin cells in varying species. In the present study, using the carbon-fiber amperometry, we investigated whether orexin A would stimulate catecholamine release from rat and mouse adrenal chromffin cells. Puff application of orexin A dose-dependently induced amperometric currents in the cultured rat chromaffin cells, which was completely blocked by the selective OX1R antagonist SB-334867 or by the removal of extracellular calcium. Likewise, in the mouse adrenal medulla slices, orexin A also induced catecholamine release mainly through the activation of OX1R. These results gain insight into our understanding of the pharmacological relevance of orexin system in modulating neuroendocrine functions. [Copyright &y& Elsevier]

• Syt11 was a short-lived protein with a half-life of 1.49 h and was degraded by a parkin-dependent UPP in neurons. • Syt11 degradation was enhanced by sustained neuronal activity. • The degradation of Syt11 in astrocytes had a half-life of 0.58 h. • The Syt11 level decreased in astrocytes under chronic hypoosmotic treatment. • The degradation of Syt11 in astrocytes was parkin-independent under both isoosmotic and hypoosmotic condition. Synaptotagmin-11 (Syt11) is associated with schizophrenia and Parkinson's disease (PD) and is a critical substrate of parkin, an E3 ubiquitin ligase linked to PD. Previously we reported that Syt11 regulates multiple membrane trafficking pathways in neurons and glia. However, the regulation of Syt11 degradation remains largely unknown. As the ubiquitin-proteasome pathway (UPP) plays crucial roles in protein degradation and quality control, we investigated UPP-dependent Syt11 degradation in this study. We found that Syt11 is a short-lived protein with a half-life of 1.49 h in the presence of a protein synthesis inhibitor cycloheximide and is mainly degraded by UPP in neurons. The degradation was further accelerated under sustained neuronal activity and was parkin-dependent. Interestingly, Syt11 had a faster turnover in astrocytes with a half-life of 0.58 h, and UPP partially contributed to its degradation. Mechanical stress applied on astrocytes by hypoosmotic treatment led to reduced Syt11 protein level but increased parkin level. However, the degradation of Syt11 was parkin-independent under both isoosmotic and hypoosmotic condition. Altogether, our results revealed active and distinct proteolytic regulation of Syt11 in neurons and astrocytes. [ABSTRACT FROM AUTHOR]